Minerva (NERV)

Minerva's (NERV) CEO Dr. Rémy Luthringer on Q2 2018 Results - Earnings Call Transcript
Aug. 5, 2018 | Price: Free! | Source: Seeking Alpha

Minerva Neurosciences' (NERV) CEO Dr. Remy Luthringer on Q1 2018 Results - Earnings Call Transcript
May 3, 2018 | Price: Free! | Source: Seeking Alpha

Minerva Neurosciences' (NERV) CEO Remy Luthringer on Q4 2017 Results - Earnings Call Transcript
March 12, 2018 | Price: Free! | Source: Seeking Alpha

Minerva Neurosciences' (NERV) CEO Dr. Remy Luthringer on Q3 2017 Results - Earnings Call Transcript
Nov. 6, 2017 | Price: Free! | Source: Seeking Alpha

Minerva Neurosciences' (NERV) CEO Remy Luthringer on Q2 2017 Results - Earnings Call Transcript
Aug. 5, 2017 | Price: Free! | Source: Seeking Alpha

Minerva Neurosciences' (NERV) CEO Tom Marano on Q1 2017 Results - Earnings Call Transcript
May 6, 2017 | Price: Free! | Source: Seeking Alpha

Minerva Neurosciences' (NERV) CEO Remy Luthringer on Q4 2016 Results - Earnings Call Transcript
March 13, 2017 | Price: Free! | Source: Seeking Alpha

Minerva Neurosciences' (NERV) CEO Remy Luthringer on Q3 2016 Results - Earnings Call Transcript
Nov. 3, 2016 | Price: Free! | Source: Seeking Alpha

Minerva Neurosciences' (NERV) CEO Remy Luthringer on Q2 2016 Results - Earnings Call Transcript
Aug. 7, 2016 | Price: Free! | Source: Seeking Alpha

Minerva Neurosciences' (NERV) CEO Remy Luthringer on Q1 2016 Results - Earnings Call Transcript
May 3, 2016 | Price: Free! | Source: Seeking Alpha

Minerva Neurosciences' (NERV) CEO Remy Luthringer on Q4 2015 Results - Earnings Call Transcript
March 14, 2016 | Price: Free! | Source: Seeking Alpha

Minerva Neurosciences' (NERV) CEO Remy Luthringer on Q3 2015 Results - Earnings Call Transcript
Nov. 7, 2015 | Price: Free! | Source: Seeking Alpha

Minerva Neurosciences' (NERV) CEO Remy Luthringer on Q2 2015 Results - Earnings Call Transcript
Aug. 9, 2015 | Price: Free! | Source: Seeking Alpha

Minerva Neurosciences' (NERV) CEO Remy Luthringer on Q1 2015 Results -- Earnings Call Transcript
May 7, 2015 | Price: Free! | Source: Seeking Alpha

Minerva's (NERV) CEO Remy Luthringer on Q4 2014 Results - Earnings Call Transcript
March 26, 2015 | Price: Free! | Source: Seeking Alpha

Minerva's (NERV) CEO Dr. Rogerio Vivaldi on Q3 2014 Results - Earnings Call Transcript
Nov. 6, 2014 | Price: Free! | Source: Seeking Alpha

Recent filings

Registration statement under Securities Act of 1933 - Aug. 10, 2018

Minerva director was just granted 40,000 options - July 17, 2018

Minerva director just declared ownership of no shares of Minerva - July 17, 2018

Minerva Neurosciences Elects Jeryl Hilleman To Board Of Directors - July 17, 2018

Minerva: 2013 Equity Incentive Plan - June 11, 2018

Minerva Just Filed Its Quarterly Report: NOTE 4 — NET LOSS P... - May 3, 2018

Minerva releases salary data. CEO sees compensation fall -26% - April 24, 2018

Minerva: Form, Schedule Or Registration Statement No Filing Party: Date Filed: - April 24, 2018

Current report, items 8.01 and 9.01 - March 22, 2018

Minerva Just Filed Its Annual Report: NOTE 4 — NET LOSS P... - March 12, 2018

Securities to be offered to employees in employee benefit plans - March 12, 2018

BlackRock, Inc. just provided an update on share ownership of Minerva - March 8, 2018

Current report, items 8.01 and 9.01 - Feb. 21, 2018

Bihua Chen just provided an update on share ownership of Minerva - Feb. 14, 2018

J. Christopher Donahue just provided an update on share ownership of Minerva - Feb. 14, 2018

Minerva Neurosciences Names Remy Luthringer As Executive Chairman And William Doyle As Lead Independent Director - Feb. 5, 2018

Minerva director was just granted 240,369 options - Feb. 2, 2018

BlackRock, Inc. just provided an update on share ownership of Minerva - Feb. 1, 2018

Minerva: “Risk Factors” In Our Filings With The Securities And Exchange Commission, Including Our Quarterly Report On Form 10-Q For The - Jan. 8, 2018

Minerva's CEO was just granted 200,000 options - Jan. 4, 2018

Securities to be offered to employees in employee benefit plans - Dec. 29, 2017

Minerva's CEO just picked up 16,556 shares - Dec. 15, 2017

Minerva's SVP & Chief Operating Officer just picked up 5,844 shares - Dec. 15, 2017

SVP of Minerva just picked up 3,339 shares - Dec. 15, 2017

Minerva's Chief Medical Officer was just granted 125,000 options - Dec. 15, 2017

Minerva's SVP and Head of R&D was just granted 175,000 options - Dec. 15, 2017

EVP of Minerva just picked up 6,671 shares - Dec. 15, 2017

Departure of Directors or Certain - Dec. 15, 2017

Minerva's President just picked up 40,000 shares - Dec. 12, 2017

Minerva director was just granted 40,000 options - Dec. 12, 2017

Minerva director was just granted 40,000 options - Dec. 12, 2017

Minerva's President just declared ownership of no shares of Minerva - Dec. 12, 2017

Minerva director just declared ownership of no shares of Minerva - Dec. 12, 2017

Minerva director just declared ownership of no shares of Minerva - Dec. 12, 2017

Minerva Neurosciences Names Richard Russell President - Dec. 11, 2017

Minerva Neurosciences Elects William Doyle And Hans Peter Hasler TO BOARD OF DIRECTORS - Dec. 11, 2017

Minerva Just Filed Its Quarterly Report: NOTE 4 — NET LOSS P... - Nov. 6, 2017

into a Material Definitive - Oct. 6, 2017

Major owner of Minerva just disposed of 3,892,256 shares - Sept. 14, 2017

Statement of acquisition of beneficial ownership by individuals - Sept. 14, 2017

Departure of Directors or Principal - Sept. 8, 2017

Minerva's SVP and Head of R&D just declared ownership of no shares of Minerva - Sept. 5, 2017

Minerva's SVP and Head of R&D was just granted 100,000 options - Sept. 5, 2017

Minerva Neurosciences Announces European Commission Approval Of AMENDMENT OF MIN-202 AGREEMENT WITH JANSSEN - Aug. 25, 2017

Minerva Just Filed Its Quarterly Report: NOTE 4 — NET LOSS P... - Aug. 3, 2017

Minerva director was just granted 50,000 options - July 26, 2017

Minerva Neurosciences Announces Departure Of Directors - July 24, 2017

Minerva just filed a prospectus, suggesting it plans to soon issue some securities - June 29, 2017

Minerva Neurosciences, Inc. To Offer Common Shares - June 29, 2017

Minerva just filed a prospectus, suggesting it plans to soon issue some securities - June 27, 2017

Entry into a Material Definitive - June 14, 2017

Minerva director was just granted 12,500 options - June 5, 2017

Minerva director was just granted 12,500 options - June 5, 2017

SVP of Minerva just cashed-in 21,631 options - June 5, 2017

Submission of Matters to a Vote of Security Holders - June 2, 2017

Minerva Announces Amended Agreement For MIN-202 IN INSOMNIA - May 31, 2017

Minerva Announces Outcome Of End-Of-Phase 2 Meeting With Fda - May 15, 2017

Minerva Just Filed Its Quarterly Report: NOTE 4 — NET LOSS P... - May 4, 2017

Minerva: Form, Schedule Or Registration Statement No Filing Party: Date Filed: - April 18, 2017

Minerva releases salary data. CEO sees compensation fall -12% - April 18, 2017

Minerva director just picked up 50,000 shares - March 21, 2017

Pursuant to the requirements of the Securities Exchange Act of - March 21, 2017

Minerva Just Filed Its Annual Report: NOTE 5 — NET LOSS P... - March 13, 2017

Securities to be offered to employees in employee benefit plans - March 13, 2017

Current report, items 8.01 and 9.01 - Feb. 27, 2017

James D. Dondero just provided an update on share ownership of Minerva - Feb. 10, 2017

EVP of Minerva just disposed of 21,450 shares - Feb. 7, 2017

Minerva's President & CEO just cashed-in 34,281 options - Feb. 7, 2017

Bihua Chen just provided an update on share ownership of Minerva - Feb. 3, 2017

Minerva: Additional Data Analyses From Phase Iib Trial Of MIN-101 SCHIZOPHRENIA UNDERSCORE BENEFIT IN MULTIPLE MEASUREMENTS OF COGNITIVE FUNCTION - Jan. 20, 2017

Minerva's SVP & Chief Operating Officer just cashed-in 1,600 options - Jan. 13, 2017

SVP of Minerva just cashed-in 17,500 options - Jan. 6, 2017

Current report, items 8.01 and 9.01 - Jan. 6, 2017

Minerva's Chief Medical Officer was just granted 145,000 options - Jan. 5, 2017

SVP of Minerva just disposed of 5,000 shares - Dec. 29, 2016

Minerva's Chief Medical Officer just declared 30,000 options - Dec. 20, 2016

Minerva's President & CEO was just granted 225,000 options and restricted shares - Dec. 16, 2016

EVP of Minerva was just granted 150,000 options and restricted shares - Dec. 16, 2016

Minerva's SVP & Chief Operating Officer was just granted 95,000 options and restricted shares - Dec. 16, 2016

SVP of Minerva was just granted 55,000 options and restricted shares - Dec. 16, 2016

SVP of Minerva was just granted 55,000 options and restricted shares - Dec. 16, 2016

Departure of Directors or Certain - Dec. 16, 2016

Major owner of Minerva just picked up 202,634 shares - Dec. 14, 2016

Major owner of Minerva just picked up 202,634 shares - Dec. 14, 2016

Major owner of Minerva just picked up 202,634 shares - Dec. 14, 2016

Minerva Neurosciences’ Clinical Data Featured At The AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY ANNUAL MEETING - Dec. 5, 2016

Minerva Just Filed Its Quarterly Report: NOTE 4 — NET LOSS P... - Nov. 3, 2016

Minerva Neurosciences Announces Positive Data From Six-Month EXTENSION OF PHASE IIB TRIAL OF MIN-101 MONOTHERAPY IN SCHIZOPHRENIA - Oct. 26, 2016

Yucca just provided an update on activist position in Minerva - Sept. 27, 2016

Major owner of Minerva just disposed of 1,000,000 shares - Aug. 12, 2016

Major owner of Minerva just disposed of 1,000,000 shares - Aug. 12, 2016

Major owner of Minerva just disposed of 1,000,000 shares - Aug. 12, 2016

Minerva Just Filed Its Quarterly Report: NOTE 4 — NET LOSS P... - Aug. 4, 2016

Minerva director just picked up 55,635 shares - June 21, 2016

Minerva director was just granted 12,500 options - June 17, 2016

Minerva director was just granted 12,500 options - June 17, 2016

Minerva director was just granted 12,500 options - June 17, 2016

Minerva director was just granted 12,500 options - June 17, 2016

Minerva director was just granted 12,500 options - June 17, 2016

Submission of Matters to a Vote of Security - June 17, 2016

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. FEDERATED INVESTORS INC /PA/ 7,535,287 0.1 June 30, 2018
2. FMR LLC 4,568,394 N/A June 30, 2018
3. Johnson & Johnson EIN 3,892,256 N/A Dec. 31, 2015
4. HIGHLAND CAPITAL MANAGEMENT LP 1,709,793 0.5 June 30, 2018
5. PRICE T ROWE ASSOCIATES INC /MD/ 1,669,963 N/A March 31, 2018
6. Care Capital III LLC 1,534,098 N/A March 22, 2016
7. VANGUARD GROUP INC 1,313,024 N/A Dec. 31, 2017
8. FRANKLIN RESOURCES INC 1,300,818 N/A June 30, 2018
9. SPHERA FUNDS MANAGEMENT LTD. 775,000 0.6 Dec. 31, 2017
10. Cormorant Asset Management, LLC 607,903 0.4 June 30, 2018
11. NEXTHERA CAPITAL LP 536,899 1.0 Sept. 30, 2017
12. BlackRock Fund Advisors 528,331 N/A Sept. 30, 2016
13. State Street Corp 477,012 N/A June 30, 2018
14. DIMENSIONAL FUND ADVISORS LP 391,041 N/A June 30, 2018
15. JPMORGAN CHASE & CO 388,300 N/A Sept. 30, 2017
16. Jefferies Group LLC 320,170 N/A June 30, 2018
17. BlackRock Institutional Trust Company, N.A. 302,650 N/A Dec. 31, 2016
18. NORTHERN TRUST CORP 302,211 N/A March 31, 2018
19. GEODE CAPITAL MANAGEMENT, LLC 297,143 N/A June 30, 2018
20. NORTHPOINTE CAPITAL LLC 255,791 0.3 June 30, 2018
21. MILLENNIUM MANAGEMENT LLC 249,026 N/A Sept. 30, 2017
22. TIAA CREF INVESTMENT MANAGEMENT LLC 169,474 N/A June 30, 2018
23. BRIDGEWAY CAPITAL MANAGEMENT INC 145,200 N/A June 30, 2018
24. DAFNA Capital Management LLC 130,872 0.5 June 30, 2018
25. Handelsbanken Fonder AB 125,000 N/A June 30, 2018
26. Bank of New York Mellon Corp 90,929 N/A June 30, 2017
27. Bank of New York Mellon Corp 90,929 N/A June 30, 2017
28. Alyeska Investment Group, L.P. 83,866 N/A June 30, 2018
29. Bank of New York Mellon Corp 78,915 N/A Dec. 31, 2016
30. BlackRock Investment Management, LLC 74,701 N/A Dec. 31, 2016

Minerva (NERV)

140
 


Feedback